Skip to main content
. 2022 May 16;66(6):e02189-21. doi: 10.1128/aac.02189-21

TABLE 3.

Ceftriaxone pharmacokinetic model parameter estimatesa

Parameter Mean (SD) Median 95% CI % RSE CV% Shrinkage (%)
TVNR (L/h) 7.27 (4.89) 6.86 5.73–8.77 11.21 67.29 7.79
TVR (L/h) 4.12 (5.47) 1.98 2.25–5.67 22.13 132.75 4.30
V (L) 7.43 (3.25) 7.25 6.45–8.33 7.29 43.66 18.50
Kon (L/mg/h) 1,290.19 (472.19) 1,312.04 1,169–1,412 6.10 36.60 27.56
Koff (h−1) 18,537.17 (4507.28) 18,961.57 17,177–19,916 4.05 24.32 17.95
Kcp (h−1) 4.00 (3.20) 3.04 3.15–4.89 13.33 80.01 24.15
Kpc (h−1) 0.65 (0.53) 0.48 0.49–0.80 13.59 81.23 16.97
N 0.82 (0.43) 0.69 0.69–0.94 8.74 51.71 21.84
a

95% CI, 95% bootstrapped confidence interval; TVNR, nonrenal ceftriaxone clearance; TVR, renal ceftriaxone clearance; V, volume of distribution; Kon, second-order association rate constant; Koff, first-order dissociation rate constant; Kcp, rate transfer constant from the central to peripheral compartment; Kpc, rate transfer constant from the peripheral to central compartment; N, number of ceftriaxone binding sites per albumin molecule; SD, standard deviation; RSE, residual squared error; CV, coefficient of variation.